| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |